Malirid-DS Tablet is a prescription antimalarial medicine containing primaquine 15 mg, used as part of treatment for certain forms of malaria and to help prevent malaria from returning in appropriate patients.

What Is Malirid-DS Tablet?

Malirid-DS Tablet contains primaquine phosphate equivalent to 15 mg of primaquine. It belongs to the antimalarial class of medicines and has an important role in eliminating certain malaria parasites that can remain in the liver after the initial infection has been treated. Product information identifies Ipca Laboratories Ltd. as the marketer/manufacturer associated with this product.

Malaria develops after infection with malaria parasites transmitted through infected mosquitoes. Treatment depends on the parasite species, geographic area, severity of infection, and the medicines already used. Malirid-DS Tablet should therefore not be considered a universal stand-alone cure for every type of malaria. A healthcare professional should determine whether primaquine is appropriate and whether another antimalarial must be given first or alongside it.

How Malirid-DS Tablet Works

Primaquine has activity against malaria parasite stages that can remain in the liver. These persistent liver forms are particularly important with certain Plasmodium vivax and Plasmodium ovale infections because they can reactivate and cause malaria to return. By targeting these parasite stages, primaquine can contribute to what clinicians call radical cure when used in an appropriate treatment regimen.

Because malaria treatment requires an accurate diagnosis, patients should not self-diagnose and start Malirid-DS Tablet simply because they have fever, chills, headache, or body aches. These symptoms can occur with many illnesses. A clinician may recommend diagnostic testing and select treatment based on the identified parasite and the patient’s individual circumstances.

Uses and Potential Benefits

Doctors may prescribe MaliridDS Tablet when primaquine is appropriate for the patient’s malaria treatment plan. One important role involves preventing relapse from malaria parasites that can remain dormant in the liver. This can be particularly relevant following treatment of susceptible P. vivax or P. ovale infections.

The medicine may also reduce the likelihood that persistent parasite stages contribute to another episode. However, it does not replace the blood-stage antimalarial treatment that may be required for the acute infection. Your healthcare professional should determine the complete regimen.

Related Product

How to Take Malirid-DS Tablet

Take MaliridDS Tablet exactly according to your prescriber’s instructions. Product information recommends taking it with or after food to reduce the possibility of stomach discomfort. Swallow the tablet with water rather than crushing or chewing it unless your healthcare professional gives different instructions.

Do not change the dose or treatment duration yourself. Missing doses can interfere with treatment, while taking more than prescribed can increase the risk of adverse effects. If you miss a dose, follow your prescriber’s or pharmacist’s instructions rather than automatically taking a double dose.

G6PD Testing Is Especially Important

One of the most important safety considerations with Malirid-DS Tablet is glucose-6-phosphate dehydrogenase (G6PD) deficiency. Primaquine can cause hemolytic anemia in people with G6PD deficiency, and the risk can be serious. Appropriate G6PD testing should be performed before primaquine treatment when recommended by clinical guidelines and the prescriber.

Tell your healthcare professional if you have ever been diagnosed with G6PD deficiency or have previously experienced unexplained anemia after taking medicines. Do not begin primaquine without appropriate medical evaluation.

Side Effects and Safety Information

Some people taking MaliridDS Tablet may experience nausea, vomiting, abdominal discomfort, headache, dizziness, rash, or other gastrointestinal symptoms. These effects may be temporary, but persistent or severe symptoms require medical advice.

Seek prompt medical attention if you develop symptoms that could indicate a serious reaction, such as unusual weakness, marked paleness, dark-colored urine, yellowing of the skin or eyes, breathing difficulty, severe dizziness, or other concerning symptoms.

Tell your healthcare professional about all prescription medicines, nonprescription medicines, vitamins, and supplements you take. This helps your clinician identify potential interactions and determine whether primaquine is appropriate.

Pregnancy, Breastfeeding, and Other Conditions

Discuss pregnancy, plans to become pregnant, and breastfeeding with your healthcare professional before using MaliridDS Tablet. Your clinician should also know about liver disease, kidney problems, blood disorders, and other significant medical conditions before prescribing treatment.

Do not give this medicine to another person, even if that person has symptoms that appear similar to yours. Malaria treatment is individualized and can vary considerably between patients.

Storage

Keep Malirid-DS Tablet in its original packaging and protect it from moisture. Store it according to the product label and keep it safely away from children.

Why Choose a Responsible Pharmacy?

When obtaining MaliridDS Tablet, patients should use a legitimate pharmacy and verify the product, strength, packaging, expiry information, and prescription requirements. Because primaquine requires important safety assessment, responsible dispensing includes checking the prescribed dose and relevant patient factors.

For online purchasing, follow applicable prescription and pharmacy laws in your country. Do not purchase medicines from an unverified seller simply because the advertised price is lower.

Frequently Asked Questions

1. What is Malirid-DS Tablet used for?

MaliridDS Tablet contains primaquine 15 mg and is used in appropriate malaria treatment regimens, particularly to eliminate certain persistent liver-stage parasites and reduce the risk of relapse.

2. Does Malirid-DS Tablet cure every type of malaria?

No. Malirid-DS Tablet is not a universal treatment for every malaria infection. The correct regimen depends on the parasite species and other clinical factors. A healthcare professional should determine the appropriate treatment.

3. Do I need a G6PD test before taking Malirid-DS Tablet?

G6PD status is an important safety consideration because primaquine can cause hemolysis in people with G6PD deficiency. Your healthcare professional should assess whether testing is required before treatment.

4. Can I take Malirid-DS Tablet with food?

Product information recommends taking the medicine with or after food to help reduce stomach upset. Follow the specific directions provided by your prescriber.

5. Can I stop Malirid-DS Tablet when I feel better?

Do not stop treatment early unless your healthcare professional tells you to do so. Completing the prescribed regimen helps achieve the intended treatment outcome.